Evolution of human immunodeficiency virus type 1 envelope sequences in infected individuals with differing disease progression profiles

Virology

Volumn 241, Issue 2, 1998, Pages 251-259

  Shankarappa, Raj ^a,b   Gupta, Phalguni ^b   Learn Jr , Gerald H ^c   Rodrigo, Allen G ^c   Rinaldo Jr , Charles R ^a,b   Gorry, Michael C ^a   Mullins, James I ^c   Nara, Peter L ^d   Ehrlich, Garth D ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; GLYCOPROTEIN GP 120; VIRUS ENVELOPE PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; CASE REPORT; CONTROLLED STUDY; DISEASE COURSE; ENVELOPE GENE; EVOLUTION; GENE AMPLIFICATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MOLECULAR CLONING; MONONUCLEAR CELL; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROVIRUS; SEROCONVERSION; T LYMPHOCYTE SUBPOPULATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0032519395     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8996     Document Type: Article

References (55)

1. Bonhoeffer S., Holmes E. C., Nowak M. A. Causes of HIV diversity. Nature. 376:1995;125.
2. Borrow P., Lewicki H., Wei X., Horwitz M. S., Peffer N., Meyers H., Nelson J. A., Gairin J. E., Hahn B. H., Oldstone M. B. A., Shaw G. M. Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nature Med. 3:1997;205-211.
3. Connor R. I., Ho D. D. HIV-1 variants with increased replicative capacity develop during the asymptomatic stage before disease progression. J. Virol. 68:1994;4400-4408.
4. +. J. Virol. 67:1993;1772-1777.
5. Deacon N. J., Tsykin A., Solomon A., Smith K., Ludford-Menting M., Hooker D. J., McPhee D. A., Greenway A. L., Ellett A., Chatfield C., Lawson J. S., Cunningham A., Dwyer D., Dowton D., Mills J. Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science. 270:1995;988-991.
6. Delwart E. L., Sheppard H. W., Walker B. D., Goudsmit J., Mullins J. I. HIV-1 evolution in vivo tracked by DNA heteroduplex mobility assays. J. Virol. 68:1994;6672-6683.
7. Desrosiers R. C. HIV with multiple gene deletions as a live attenuated vaccine for AIDS. Aids Res. Hum. Retroviruses. 8:1992;411-421.
8. Dewhurst S., Embretson J. E., Anderson D. C., Mullins J. I., Fultz P. N. Sequence analysis and acute pathogenicity of molecularly cloned SIV(SMM-PBj14). Nature. 345:1990;636-640.
9. Eckert R. A., Kunkel T. A. DNA polymerase fidelity and the polymerase chain reaction. PCR Methods Appl. 1:1991;17-24.
10. Ehrlich G. D. Caveats of PCR. Clin. Microbiol. Newslett. 13:1991.
11. Ehrlich G. D., Greenberg S. J., Abbott M. Detection of human T-cell lymphoma/leukemia viruses (HTLV). PCR Protocols: A Guide to Methods and Applications. 1990;Academic Press, San Diego. p. 325-336.
12. Ehrlich G. D., Glaser J. B., Maese J., Bryz-Gornia V., Waldmann T. A., Poiesz B. J., Greenberg S. J. Multiple sclerosis, retroviruses and PCR. Neurology. 41:1991;335-343.
13. Felsenstein, 1993, Seattle, WA.
14. Furtado M. R., Kingsley L. A., Wolinsky S. M. Changes in the viral mRNA expression pattern correlate with a rapid rate of CD4+ T-cell number decline in HIV-1-infected individuals. J. Virol. 69:1995;2092-2100.
15. Ganeshan S., Dickover R. E., Korber B. T., Bryson Y. J., Wolinsky S. M. Human immunodeficiency virus type 1 genetic evolution in children with different rates of development of disease. J. Virol. 71:1997;663-677.
16. Gojobori T., Moriyama E. N., Kimura M. Molecular clock of viral evolution, and the neutral theory. Proc. Natl. Acad. Sci. USA. 87:1990;10015-10018.
17. Hirsch V. M., Edmonson P., Murphey-Corb M., Arbielle B., Johnson P. R., Mullins J. I. SIV adaption to human cells (letter). Nature. 341:1989;572-574.
18. Ho D. D., Neumann A. U., Perelson A. S., Chen W., Leonard J. M., Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature. 373:1995;123-126.
19. Iversen A. K. N., Shpaer E. G., Rodrigo A. G., Hirsch M. S., Walker B. D., Sheppard H. W., Merigan T. C., Mullins J. I. Persistence of attenuated Rev genes in an HIV-1 infected asymptomatic individual. J. Virol. 69:1995;5743-5753.
20. Kimura M. A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J. Mol. Evol. 16:1980;111-120.
21. Kirchhoff F., Greenough T. C., Brettler D. B., Sullivan J. L., Desrosiers R. C. Absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. N. Engl. J. Med. 332:1995;228-232.
22. Klein M. R., van Baalen C. A., Holwerda A. M., Kerkhof-Garde S. R., Bende R. J., Keet I. P., Eeftinck-Schattenkerk J. K., Osterhaus A. D., Schuitemaker H., Miedema F. Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: A longitudinal analysis of rapid progressors and long-term asymptomatics. J. Exp. Med. 181:1995;1365-1372.
23. Kliks S. C., Shioda T., Haigwood N. L., Levy J. A. V3 variability can influence the ability of an antibody to neutralize or enhance infection by diverse strains of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA. 90:1993;11518-11522.
24. Köhler H., Mûller S., Nara P. Deceptive imprinting in the immune response against HIV-1. Immunol. Today. 15:1994;475-478.
25. Köhler H., Goudsmit J., Nara P. L. Clonal dominance in HIV-1 infection: Cause for a limited and failing immune response. J. Acquir. Immune. Defic. Syndr. 5:1992;1158-1168.
26. Kumar S., Tamura K., Nei M. MEGA: Molecular Evolutionary Genetics Analysis software for microcomputers. Comput. Appl. Biosci. 10:1994;189-191.
27. Learn G. H., Korber B. T. M., Foley B., Hahn B. H., Wolinsky S. M., Mullins J. I. Maintaining the integrity of HIV sequence databases. J. Virol. 70:1996;5720-5730.
28. Liu S.-L., Rodrigo A. G., Shankarappa R., Learn G. H., Hsu L., Davidov O., Zhao L. P., Mullins J. I. HIV quasispecies and resampling. Science. 273:1996;415-416.
29. Liu S.-L., Schacker T., Musey L., McElrath M. J., Corey L., Mullins J. I. Divergent patterns of progression to AIDS after infection from the same source: Human immunodeficiency virus type 1 evolution and antiviral responses. J. Virol. 71:1997;4284-4295.
30. Lukashov V. V., Kuiken C. L., Goudsmit J. Intrahost HIV-1 evolution is related to length of the immunocompetent period. J. Virol. 69:1995;6911-6916.
31. McNearney T., Hornickova Z., Markham R., Birdwell A., Arens M., Saah A., Ratner L. Relationship of human immunodeficiency virus type 1 sequence heterogeneity to stage of disease. Proc. Natl. Acad. Sci. USA. 89:1992;10247-10251.
32. Mellors J. W., Rinaldo J., Gupta P., White R. M., Todd J., Kingsley L. A. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science. 272:1996;1167-1170.
33. Michael N. L., Morrow P., Mosca J., Vahey M., Burke D. S., Redfield R. R. Induction of human immunodeficiency virus type 1 expression in chronically infected cells is associated primarily with a shift in RNA splicing patterns. J. Virol. 65:1991;1291-1303.
34. Milich L., Margolin B., Swanstrom R. V3 loop of the HIV-1 Env protein: Interpreting sequence variability. J. Virol. 67:1993;5623-5634.
35. Mullins J. I., Hoover E. A., Quackenbush S. L., Donahue P. R. Disease progression and viral genome variants in experimental feline leukemia virus-induced immunodeficiency syndrome. J. Acquir. Immune Defic. Syndr. 4:1991;547-557.
36. Nowak M. A., Anderson R. M., McLean A. R., Wolfs T. F., Goudsmit J., May R. M. Antigenic diversity thresholds and the development of AIDS. Science. 254:1991;963-969.
37. Pang S., Shlesinger Y., Daar E. S., Moudgil T., Ho D. D., Chen I. S. Y. Rapid generation of sequence variation during primary HIV-1 infection. AIDS. 6:1992;453-460.
38. Pearson W. R., Lipman D. J. Improved tools for biological sequence comparison. Proc. Natl. Acad. Sci. USA. 85:1988;2444-2448.
39. Perelson A. S., Neumann A. U., Markowitz M., Leonard J. M., Ho D. D. HIV-1 dynamics in vivo: Virion clearance rate, infected cell life-span, and viral generation time. Science. 271:1996;1582-1586.
40. Rinaldo C. R., Huang X. L., Fan Z. F., Ding M., Beltz L., Logar A., Panicali D., Mazzara G., Liebmann J., Cottrill M. High levels of anti-HIV-1 memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors. J. Virol. 69:1995;5838-5842.
41. Rodrigo A. G., Mullins J. I. HIV-1 molecular evolution and the measure of selection. AIDS Res. Hum. Retrovir. 12:1996;1681-1685.
42. Saitou N., Nei M. The neighbour-joining method: A new method for reconstructing phylogenetic trees. Mol. Biol. Evol. 4:1987;406-425.
43. Saksela K., Stevens C., Rubinstein P., Baltimore D. Human immunodeficiency virus type 1 mRNA expression in peripheral blood cells predicts disease progression independently of the numbers of CD4+ lymphocytes. Proc. Natl. Acad. Sci. USA. 91:1994;1104-1108.
44. Schuitemaker H., Koot M., Kootstra N. A., Dercksen M. W., de Goede R. E., van Steenwijk R. P., Lange J. M., Schattenkerk J. K., Miedema F., Tersmette M. Biological phenotype of HIV-1 clones at different stages of infection: Progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population. J. Virol. 66:1992;1354-1360.
45. Sirko D. A., Ehrlich G. D. PCR laboratory facilities, protocols and operations. Ehrlich a. S. J. G. G. D. PCR-Based Diagnostics in Infectious Disease. 1994;19-44 Blackwell Scientific, Boston.
46. Smith M. W., Dean M., Carrington M., Winkler C., Huttley G. A., Lomb D. A., Goedert J. J., O'Brien T. R., Jacobson L. P., Kaslow R., Buchbinder S., Vittinghoff E., Vlahov D., Hoots K., Hilgartner M. W., O'Brien S. J. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MACS), San Francisco City Cohort (SFCC), ALIVE Study. Science. 277:1997;959-965.
47. Tersmette M., de Goede R. E. Y., Al B. J. M., Winkel I. N., Gruters R. A., Cuypers H. T., Huisman H. G., Miedema F. Differential syncytium-inducing capacity of HIV isolates: Frequent detection of syncytium-inducing isolates in patients with AIDS and AIDS-related complex. J. Virol. 62:1988;2026-2032.
48. Tersmette M., Gruters R. A., de Wolf F., de Goede R. E. Y., Lange J. M. A., Schellekens P. T. A., Goudsmit J., Huisman H. G., Miedema F. Evidence for a role of virulent HIV variants in the pathogenesis of AIDS: Studies on sequential HIV isolates. J. Virol. 63:1989;2118-2125.
49. Wei X., Ghosh S. K., Taylor M. E., Johnson V. A., Emini E. A., Deutsch P., Lifson J. D., Bonhoeffer S., Nowak M. A., Hahn B. H., Saag M. S., Shaw G. M. Viral dynamics of HIV-1 infection. Nature. 373:1995;117-122.
50. Wolfs T. F., Zwart G., Bakker M., Goudsmit J. HIV-1 genomic RNA diversification following sexual and parenteral virus transmission. Virology. 189:1992;103-110.
51. Wolfs T. F., Zwart G., Bakker M., Valk M., Kuiken C. L., Goudsmit J. Naturally occurring mutations within HIV-1 V3 genomic RNA lead to antigenic variation dependent on a single amino acid substitution. Virology. 185:1991;195-205.
52. Wolinsky S. M., Korber B. T. M., Neumann A. U., Daniels M., Kuntsman K. J., Whetsell A. J., Furtado M. R., Cao Y., Ho D. D., Safrit J. T., Koup R. A. Adaptive evolution of HIV-1 during the natural course of infection. Science. 272:1996;537-542.
53. Wolinsky S. M., Wike C. M., Korber B. T. M., Hutto C., Parks W. P., Rosenblum L. L., Kunstman K. J., Furtado M. R., Muñoz J. L. Selective transmission of HIV-1 variants from mother to infants. Science. 255:1992;1134-1137.
54. Zhang L. Q., MacKenzie P., Cleland A., Holmes E. C., Leigh Brown A. J., Simmonds P. Selection for specific sequences in the external envelope protein of HIV-1 upon primary infection. J. Virol. 67:1993;3345-3356.
55. Zhu T., Mo H., Wang N., Nam D. S., Cao Y., Koup R. A., Ho D. D. Genotypic and phenotypic characterization of HIV-1 in patients with primary infection. Science. 261:1993;1179-1181.